Marc Elia serves as Executive at Adagio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Marc Elia has executed 3 insider transactions totaling $12.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 19, 2022 involved purchasing 584,451 shares valued at $2.7M.
Marc Elia currently holds 9,248,250 shares of Adagio Therapeutics, Inc. (ADGI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Elia has been a net buyer of ADGI stock. They have purchased $12.2M and sold $0 worth of shares.
Marc Elia's most recent insider trade was on Aug 19, 2022, when they purchased 584,451 shares at $4.62 per share.
Get notified when new Form 4 filings are submitted
| $4.31 |
| Discretionary |
| Aug 17, 2022 | ADGI | $4.0M | Purchase | 1,000,000 | $4.04 | Discretionary |